Pharmaceutical News

RSS

Potential side effects increase in children with use of common reflux aids, study shows

Proton Pump Inhibitors (PPIs) -- such as Prilosec, Protonix and Nexium, have long been one of the most prescribed medications in the country to aid in the reduction of stomach acid.

7 Nov 2019

Rapamycin prevents age-related brain vascular deterioration, study shows

A just-released study by UT Health San Antonio and collaborating institutions shows age-related decreases in blood flow to the brain and memory loss can be modified with the drug rapamycin.

6 Nov 2019

E-learning educates medical students on safely prescribing opioids for chronic pain

Even in the era of the opioid epidemic and abuse, medical residents report feeling inadequately prepared to prescribe opioids responsibly to patients who medically need them. However, a safe opioid prescribing e-learning program effectively educates graduate students on safely prescribing opioids for chronic pain and is effective regardless of year in training, according to research from the University of California, Irvine.

6 Nov 2019

Study: Medication use is common in pregnant women with preeclampsia

Use of medications during pregnancy is more common in women with preeclampsia than in those without, according to an analysis of women who gave birth at a hospital in Finland in 2002-2016.

6 Nov 2019

Electronic prescription accountability program may help track opioid prescriptions

An electronic prescription accountability program for physicians tracking the number of opioid prescriptions per provider may help institutions identify areas for training and education to prevent overprescribing, according to research from the University of California, Irvine.

6 Nov 2019

AnaBios receives IDIQ contract to assess drug safety related to cardiac function

The U.S. Food and Drug Administration (FDA) has awarded AnaBios an exclusive Indefinite Delivery Indefinite Quantity (IDIQ) contract to employ adult human primary tissues and cardiomyocytes from organ donors to assess drug safety related to cardiac function.

6 Nov 2019

Study identifies several drugs with potential to prevent suicide attempts

A review of 922 prescription medications taken by almost 150 million people over an 11-year period shows that just 10 of these drugs were associated with an increased rate of suicide attempts.

5 Nov 2019

Researchers successfully treat pain using nanoparticles to deliver a non-opioid medication

The use of nanoparticles to deliver a drug into specific nerve cells has resulted in significantly improved pain relief.

5 Nov 2019

FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns

After unanimously voting to recommend a miraculous hepatitis C drug for approval in 2013, a panel of experts advising the Food and Drug Administration gushed about what they'd accomplished.

5 Nov 2019

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Eisai Co., Ltd. announced today that it has entered into an agreement to transfer the rights to receive royalties on the sales outside of Japan for an investigational anti-cancer agent tazemetostat (generic name) to Royalty Pharma.

5 Nov 2019

Panelists explore the issue of drug pricing at ISPOR Europe 2019

ISPOR, the professional society for health economics and outcomes research - explored the issue of drug pricing in the session, "Time for Change? Has the Time Come for the Pharma Industry to Accept Modest Prices?" [IP4].

5 Nov 2019

ASA commends FDA for identifying root causes and solutions to drug shortages

On October 29, the inter-agency Drug Shortages Task Force led by the U.S. Food and Drug Administration issued a report titled "Drug Shortages: Root Causes and Potential Solutions" at the request of Congress.

4 Nov 2019

Discovery of human cell signaling systems using bioinformatics

There are many and various receptors on the surface of each human cell, which bind to specific molecules called ligands, to set off signals that modulate cell activity accordingly. These pathways are exploited by therapeutic drugs. In fact, one in three drugs makes use of receptors belonging to a single very large family – the GPCR (G protein receptor coupled receptor) family.

1 Nov 2019

Good news, bad news: lower antibiotic use, more antibiotic resistance in UK

Public Health England (PHE) is cheering about a significant fall in the number of antibiotic prescriptions in England over the five years between 2014 and 2019, when it has dropped by 17%. However, with more and more bacterial infections showing antibiotic resistance every single year, there is no room for complacency.

31 Oct 2019

Portage, Geauga and Lake counties to get new drug prevention infrastructures

Kent State University's College of Public Health is teaming up with the Department of Computer Science to develop and implement drug prevention infrastructure in Portage, Geauga and Lake counties.

30 Oct 2019

Drug delivery still has great development potential

Nanocapsules and other containers can transport drugs through a patient's body directly to the origin of the disease and release them there in a controlled manner. Such sophisticated systems are occasionally used in cancer therapy. Because they work very specifically, they have fewer side effects than drugs that are distributed throughout the entire organism.

30 Oct 2019

Kazan University showcases innovative antiseptic in Vienna

The event was co-organized by the Ministry of Industry and Trade of Russia, Skolkovo, Russian Venture Company, ChemRar, RDI Group, Vienna Business Agency, and others.

30 Oct 2019

Rilpivirine drug used for HIV treatment also suppresses Zika virus infection

Like an adjustable wrench that becomes the "go-to" tool because it is effective and can be used for a variety of purposes, an existing drug that can be adapted to halt the replication of different viruses would greatly expedite the treatment of different infectious diseases.

30 Oct 2019

New grant funds innovative approach to bladder cancer treatment

The San Antonio Medical Foundation has awarded Texas Biomedical Research Institute Professor Jordi B. Torrelles, Ph.D., with a $173,000 grant to study a modified Mycobacterium bovis Bacillus Calmette et Guérin (BCG) vaccine shown to have promise for treating bladder cancer.

30 Oct 2019

DGIST and Ahn-Gook Pharmaceutical sign R&D agreement for development of anti-cancer antibody

A research group, led by Professor Kyungmoo Yea at the Department of New Biology, DGIST has signed an agreement on the joint R&D for the development of anti-cancer antibody with Ahn-Gook Pharmaceutical Co., Ltd. in September.

30 Oct 2019

Pharmaceutical News

Potential side effects increase in children with use of common reflux aids, study shows

Rapamycin prevents age-related brain vascular deterioration, study shows

E-learning educates medical students on safely prescribing opioids for chronic pain

Study: Medication use is common in pregnant women with preeclampsia

Electronic prescription accountability program may help track opioid prescriptions

AnaBios receives IDIQ contract to assess drug safety related to cardiac function

Study identifies several drugs with potential to prevent suicide attempts

Researchers successfully treat pain using nanoparticles to deliver a non-opioid medication

FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns

Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan

Panelists explore the issue of drug pricing at ISPOR Europe 2019

ASA commends FDA for identifying root causes and solutions to drug shortages

Discovery of human cell signaling systems using bioinformatics

Good news, bad news: lower antibiotic use, more antibiotic resistance in UK

Portage, Geauga and Lake counties to get new drug prevention infrastructures

Drug delivery still has great development potential

Kazan University showcases innovative antiseptic in Vienna

Rilpivirine drug used for HIV treatment also suppresses Zika virus infection

New grant funds innovative approach to bladder cancer treatment

DGIST and Ahn-Gook Pharmaceutical sign R&D agreement for development of anti-cancer antibody

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Latest News